Volfova Pavlina, Lengerova Martina, Lochmanova Jana, Dvorakova Dana, Ricna Dita, Palackova Martina, Weinbergerova Barbora, Mayer Jiri, Racil Zdenek
Department of Internal Medicine-Hematology and Oncology, University Hospital Brno, Brno, Czech Republic.
Department of Internal Medicine-Hematology and Oncology, University Hospital Brno, Brno, Czech Republic; Faculty of Medicine, Masaryk University, Brno, Czech Republic; CEITEC-Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
J Clin Virol. 2014 Oct;61(2):270-4. doi: 10.1016/j.jcv.2014.07.008. Epub 2014 Jul 22.
Antiviral resistance development is a serious complication of human cytomegalovirus virostatic therapy caused by mutations in UL 97 and/or UL54 genes.
To determinate the presence of sensitive and resistant strains in patients developing antiviral resistance.
We used three different molecular biological methods for mutation analysis-restriction fragment length polymorphism, sequencing and real-time PCR approach.
We describe three allogeneic hematopoietic stem cell transplant patients developing the GCV resistant HCMV strains manifested by virostatic treatment failure. In these patients we identified UL97 mutations L595S, A594V and A594T and monitored the dynamics of coexisted sensitive/resistant strains. We confirmed the presence of mixed HCMV populations and in two patients a phenomenon of sensitive strain repopulation which occurred after 6.5 months and 1 month after removing GCV pressure.
Our results show changes in proportions of sensitive/resistant subpopulations over time but other studies would be required to demonstrate the beneficial impact of their monitoring on clinical outcome.
